Publications
Search our publications, laboratory reports, meeting statements, scheduling submissions and scheduling decisions.
Can't find what you’re looking for? You can also:
- search our Resources
- use the site search bar in the top right of this screen for more results.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Committees and advisory bodies (378)
- Scheduling (national classification system) (176)
- Safety monitoring and information (31)
- COVID-19 (11)
- Manufacturing (11)
- Advertising (9)
- Clinical trials (8)
- Medicinal cannabis hub (6)
- Compliance and enforcement (5)
- Fees and payments (5)
- Sunscreens (5)
- Shortages and supply disruptions (4)
- Legislation (3)
- Breast implant hub (1)
- Import and export (1)
- Labelling and packaging (1)
- Metal-on-metal hip replacement implants hub (1)
- Prescription opioids hub (1)
- Unique Device Identification (UDI) hub (1)
Search
773 result(s) found, displaying 376 to 400
-
Corporate reportsGuidance for procurement areas in hospitals, aged care residential facilities and other facilities.
-
Corporate reportsThis Points to Consider document lays out a regulatory approach for updating authorised coronavirus vaccines should mutations at any time make them less efficacious due to insufficient cross-reactivity.
-
Meeting statementsDetails about meeting 1 for the Medical Device Consumer Working Group (MDCWG) held in 2019.
-
Meeting statementsDetails about meeting 2 for the Medical Device Consumer Working Group (MDCWG) held in 2020.
-
Meeting statementsDetails about meeting 3 for the Medical Device Consumer Working Group (MDCWG) held in 2020.
-
Meeting statementsDetails about meeting 4 for the Medical Device Consumer Working Group (MDCWG) held in 2020.
-
Meeting statementsAdvisory Committee on Vaccines meeting statement
-
-
Scheduling decisions (interim)Interim decisions and invitation for further comment. Closing date: 4 March 2021.
-
Scheduling submissionsPublic submissions made in response to the proposed amendments to the Poisons Standard published on 26 August 2020
-
Meeting statementsAdvisory Committee on Vaccines meeting statement
-
Meeting statementsAdvisory Committee on Complementary Medicines meeting statement for 10 November 2020
-
Meeting statementsAdvisory Committee on Vaccines meeting statement
-
Meeting statementsAdvisory Committee on Vaccines meeting statement
-
Scheduling submissionsPublic submissions made in response to the interim decisions published on 9 September 2020
-
Corporate reportsTargets have been met for the measures under the six KPIs
-
Scheduling decisions (final)Public notice of the delegate's final decision to amend the current Poisons Standard in relation to nicotine
-
Scheduling submissionsPublic submissions made in response to the interim decision on nicotine scheduling published on 23 September 2020
-
Corporate reportsProposal to prevent the uptake of nicotine containing e-cigarettes by ever users (adolescents and young adults), to support smoking cessation and to reduce nicotine poisonings of children
-
Scheduling decisions (final)Public notice of the delegate's final decision to amend the Poisons Standard in relation to cannabidiol (private application and delegate initiated) - Joint ACMS-ACCS #25 and #26 (June and November 2020).
-
Scheduling decisions (final)Decisions to be included in the February 2021 Poisons Standard
-
Meeting statementsAdvisory Committee on Medical Devices meeting statement.
-
Meeting statementsAdvisory Committee on Medicines meeting statement
-
TGA laboratory testing reportsThe TGA has released a report summarising the recent laboratory testing of medicinal cannabis products
-
Corporate reportsInsights into therapeutic goods safety regulatory activity for our recalls program.